Page last updated: 2024-08-23

paclitaxel and Injuries, Radiation

paclitaxel has been researched along with Injuries, Radiation in 54 studies

Research

Studies (54)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (9.26)18.2507
2000's31 (57.41)29.6817
2010's17 (31.48)24.3611
2020's1 (1.85)2.80

Authors

AuthorsStudies
Exner, F; Flentje, M; Höcht, S; Kleine, P; Mantel, F; Müller, E; Polat, B; Richter, A; Ströhle, S; Weick, S; Zimmermann, M1
Chang, B; Dahl, DM; George, A; Hu, C; Lee, RJ; Lee-Wu, C; Michaelson, MD; Pham, HT; Sandler, H; Shipley, W; Souhami, L; Swanson, GP; Vuky, J1
Ahn, SJ; Ban, HJ; Chung, WK; Kim, KS; Kim, YC; Kim, YI; Kwon, YS; Lim, SC; Nam, TK; Oh, IJ; Song, JY; Yoon, MS1
Batus, M; Bonomi, P; Dandekar, VK; Fidler, MJ; Kiel, K; Sher, DJ; Young, J1
Dilling, TJ1
Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y1
Ahn, SJ; Ban, HJ; Chung, WK; Jeong, JU; Kim, KS; Kim, YC; Kim, YH; Nam, TK; Oh, IJ; Song, JY; Yoon, MS1
Fei, Z; Jin, X; Li, L; Lin, B; Pan, Q; Su, H; Xie, C; Xue, S; Zhang, X; Zhao, H; Zhao, L1
Barillot, I; Charra Brunaud, C; Haie-Méder, C; Kerr, C; Peignaux, K; Thomas, L1
Browne, JD; D'Agostino, RB; Greven, KM; McGuirt, WF; White, DR; Williams, DW1
Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C1
Albert, PS; Citrin, D; Colevas, AD; Cooley-Zgela, T; Cotrim, A; Herscher, L; Likhacheva, A; Mansueti, J; Morris, JC; Rudy, SF; Russo, A; Sciuto, L; Smith, S; Solomon, B; Van Waes, C1
Chung, CH; Cmelak, AJ; Diaz, R; Gilbert, J; Jaboin, JJ; Koehler, E; Morales-Paliza, M; Murphy, BA; Murphy, PB; Phillips, JG; Shyr, Y; Stinson, S; Yarbrough, WG1
Bryant, AS; Cerfolio, RJ; Talati, A1
Day, TA; Garrett-Mayer, E; Gillespie, MB; Sharma, AK; Shirai, K; Wahlquist, AH; Watkins, JM; Zauls, AJ1
Deng, X; Hu, W; Li, G; Wang, J; Wu, S; Xie, C; Zhang, P; Zhang, X1
Guntinas-Lichius, O; Klubmann, JP; Müller, RP; Preuss, SF; Semrau, R; Temming, S1
Eisbruch, A; Feng, F; Pak, D; Ten Haken, RK; Vineberg, K1
Chang, JY; Cox, JD; Koay, EJ; Komaki, R; Lege, D; Mohan, R1
Chen, EC; Chen, XM; Hao, CG; Ma, JB; Qin, G; Song, YP; Wei, L1
Deschesne, K; Fraser, R; Halle, JS; Johnson, H; Moore, DT; Morris, DE; Rosenman, JG; Socinski, MA1
Hunter, N; Li, C; Mason, KA; Milas, L; Wallace, S1
Senzer, N1
Braaksma, M; Levendag, P1
Cho, MJ; Kim, JS; Kim, Ki; Kim, SY1
Ang, P; Ang, PT; Chew, L; Fong, KW; Foo, KF; Lee, KM; Leong, SS; Lim, SH; Ong, YK; Tai, BC; Tan, EH; Wee, J; Wilder-Smith, E1
Aston, D; Brewster, AE; Crosby, TD; Minett, M; Mukherjee, S1
Antonadou, D; Bolanos, N; Petridis, A; Sagriotis, A; Synodinou, M; Throuvalas, N1
Bratengeier, K; Flentje, M; Hagen, R; Helms, J; Hoppe, F; Pfreundner, L; Preisler, V; Willner, J1
Csuka, O; Koronczay, K; Lövey, J; Németh, G; Remenár, E1
Corey, B; Savarese, DM; Savy, G; Vahdat, L; Wischmeyer, PE1
Antonadou, D; Bolanos, N; Petridis, A; Sagriotis, A; Synodinou, M; Throuvalas, N; Veslemes, M1
Costello, R; Haddad, R; Posner, M; Weeks, L; Wirth, L1
Axelrod, R; Byhardt, R; Komaki, R; Langer, C; Machtay, M; Movsas, B; Nicolaou, N; Sarna, L; Scott, C; Smith, C; Wasserman, T; Werner-Wasik, M1
Harman, EM; Keene, KS; Knauf, DG; McCarley, D; Zlotecki, RA1
Biel, MA; El-Naggar, AK; Machtay, M; Rosenthal, DI; Sinard, RJ; Weber, RS; Yom, SS1
Dworkin, RH; Griggs, J; Herrmann, D; Jung, BF; Oaklander, AL1
Baas, P; Belderbos, JS; Burgers, JA; Kwa, HB; Senan, S; van Bochove, A; van Meerbeeck, JP; van Tinteren, H1
Carey, MS; D'Souza, D; Gawlik, C; Kwon, J; Lupe, K; Nascu, P; Stitt, L; Whiston, F; Wong, E1
Bradley, J; Gilstrap, E; Govindan, R; Velcheti, V1
Christie, D; Kennedy, T; Law, A; Pellitteri, P; Wood, C; Yumen, O1
Aapro, MS; Zulian, GB1
Bajada, CL; Juillard, GJ; Parker, RG; Schweitzer, VG1
Altmannsberger, HM; Hassenstein, EO; Rexroth, G; Rösch, W1
Bavbek, S; Kaytan, E; Kizir, A; Oral, EN; Tenececi, N; Topuz, E; Yöney, A1
Aletti, G; Beatrice, S; Carnelli, M; Ferrari, A; Frigerio, L; Garavaglia, E; Mangili, G1
Borgmeier, A; Flentje, M; Huber, RM; Kirschner, J; Lang, S; Schmidt, M; Willner, J1
Prescott, LM1
Abe, M; Endo, M; Hirota, S; Hishikawa, Y; Kado, T; Kono, M; Kotani, Y; Obayashi, K; Satouchi, M; Takada, Y; Tsujino, K1
Frankel, LS; Liu, L; Munoz, LK; Rosenthal, DI; Strauss, LC; Vapiwala, N; Weitman, S; Winick, NJ1
Fleming, D; Hahl, M; Morkas, M1
Axelrod, RS; Chapman, AE; Curran, WJ; Deshields, M; Friedland, DP; Grubbs, S; Hauck, W; Rose, LJ; Werner-Wasik, M1

Reviews

5 review(s) available for paclitaxel and Injuries, Radiation

ArticleYear
Radiation dose in non-small cell lung cancer: too much of a good thing?
    International journal of radiation oncology, biology, physics, 2014, Dec-01, Volume: 90, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Dose Fractionation, Radiation; Hospitals, High-Volume; Humans; Incidence; Lung Neoplasms; Paclitaxel; Quality of Life; Radiation Injuries; Radiotherapy Dosage; Retreatment; Retrospective Studies; Treatment Outcome

2014
Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    International journal of radiation oncology, biology, physics, 2003, Apr-01, Volume: 55, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Hematologic Diseases; Humans; Hysterectomy; Life Tables; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Nausea; Neoplasm Metastasis; Paclitaxel; Radiation Injuries; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms

2003
Prevention of chemotherapy and radiation toxicity with glutamine.
    Cancer treatment reviews, 2003, Volume: 29, Issue:6

    Topics: Anthracyclines; Antineoplastic Agents; Dietary Supplements; Digestive System; Glutamine; Glutathione; Heart Diseases; Humans; Neoplasms; Paclitaxel; Radiation Injuries

2003
Neuropathic pain associated with non-surgical treatment of breast cancer.
    Pain, 2005, Volume: 118, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Models, Animal; Female; Humans; Neuralgia; Paclitaxel; Peripheral Nerves; Peripheral Nervous System Diseases; Radiation Injuries; Radiotherapy; Rats

2005
Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Drug Hypersensitivity; Esophagitis; Humans; Leukopenia; Life Tables; Lung Neoplasms; Maximum Tolerated Dose; Nausea; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vomiting

2001

Trials

26 trial(s) available for paclitaxel and Injuries, Radiation

ArticleYear
A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524).
    International journal of radiation oncology, biology, physics, 2017, 04-01, Volume: 97, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cystectomy; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Paclitaxel; Radiation Injuries; Trastuzumab; Treatment Outcome; Urethra; Urinary Bladder Neoplasms

2017
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.
    Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiotherapy, Conformal; Survival Rate; Taxoids; Treatment Outcome

2013
PL03.05 An intergroup randomized phase III comparison of standard-dose (60 Gy) vs high-dose (74 Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): results on cetux from RTOG 0617.
    Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:1 Suppl 1

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cetuximab; Chemoradiotherapy; Consolidation Chemotherapy; Disease-Free Survival; ErbB Receptors; Esophagitis; Female; Humans; Lung Neoplasms; Male; Neoplasm Proteins; Paclitaxel; Protein Kinase Inhibitors; Radiation Injuries; Radiotherapy Dosage; Survival Analysis

2014
O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study.
    Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Consolidation Chemotherapy; Disease-Free Survival; DNA Mutational Analysis; DNA, Neoplasm; Docetaxel; Erlotinib Hydrochloride; Esophagitis; Genes, erbB-1; Humans; Lung Neoplasms; Paclitaxel; Prospective Studies; Quinazolines; Radiation Injuries; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Analysis; Taxoids

2014
Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
    Oncotarget, 2016, Oct-25, Volume: 7, Issue:43

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemoradiotherapy, Adjuvant; Cisplatin; Consolidation Chemotherapy; Disease-Free Survival; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Radiation Injuries; Treatment Outcome; Uterine Cervical Neoplasms

2016
High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers.
    American journal of clinical oncology, 2008, Volume: 31, Issue:6

    Topics: Adult; Aged; Amines; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Gefitinib; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Paresthesia; Prognosis; Quinazolines; Radiation Injuries; Radiotherapy; Stomatitis

2008
Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma.
    International journal of radiation oncology, biology, physics, 2010, Dec-01, Volume: 78, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; ErbB Receptors; Erlotinib Hydrochloride; Esophageal Neoplasms; Feasibility Studies; Follow-Up Studies; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Paclitaxel; Protein Kinase Inhibitors; Quinazolines; Radiation Injuries; Radiotherapy Dosage; Thrombocytopenia

2010
Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2011, Volume: 187, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Dose Fractionation, Radiation; Enteral Nutrition; Feasibility Studies; Female; Follow-Up Studies; Germany; Humans; Hypopharyngeal Neoplasms; Leukopenia; Male; Middle Aged; Mucositis; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy Dosage; Thrombocytopenia

2011
Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.
    International journal of radiation oncology, biology, physics, 2012, Dec-01, Volume: 84, Issue:5

    Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagus; Female; Humans; Lung Neoplasms; Male; Organs at Risk; Paclitaxel; Prospective Studies; Proton Therapy; Protons; Radiation Injuries; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Spinal Cord; Treatment Outcome; Tumor Burden

2012
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
    International journal of radiation oncology, biology, physics, 2002, Oct-01, Volume: 54, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Radiation Injuries; Radiotherapy Dosage; Remission Induction; Survival Analysis; Treatment Failure

2002
A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings.
    Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 19

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cytoprotection; Deoxycytidine; Esophagitis; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation-Protective Agents

2002
Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
    Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 19

    Topics: Amifostine; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cytoprotection; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Radiotherapy, Conformal; Tomography, X-Ray Computed; Xerostomia

2002
Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Double-Blind Method; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Placebos; Radiation Injuries; Radiation-Protective Agents; Treatment Outcome

2003
Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
    International journal of radiation oncology, biology, physics, 2003, Oct-01, Volume: 57, Issue:2

    Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Paclitaxel; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents; Radiotherapy Dosage; Stomatitis; Treatment Outcome

2003
Radiotherapy and concurrent low-dose paclitaxel in locally advanced head and neck cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2003, Volume: 68, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Survival Rate

2003
Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
    Seminars in oncology, 2003, Volume: 30, Issue:6 Suppl 18

    Topics: Aged; Amifostine; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents; Radiation-Sensitizing Agents

2003
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.
    Seminars in oncology, 2003, Volume: 30, Issue:6 Suppl 18

    Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Stomatitis; Xerostomia

2003
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-01, Volume: 23, Issue:10

    Topics: Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deglutition Disorders; Dose Fractionation, Radiation; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Quality of Life; Radiation Injuries; Radiation-Protective Agents; Survival Analysis; Treatment Outcome

2005
Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Female; Follow-Up Studies; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Radiation Injuries; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Survival Analysis; Survival Rate; Treatment Outcome

2005
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
    British journal of cancer, 2006, Mar-13, Volume: 94, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Radiation Injuries; Survival Analysis; Treatment Outcome

2006
Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
    International journal of radiation oncology, biology, physics, 2007, Dec-01, Volume: 69, Issue:5

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Injections, Subcutaneous; Male; Middle Aged; Mucositis; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage; Xerostomia

2007
Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1999, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Retrospective Studies

1999
Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study.
    Gynecologic oncology, 2001, Volume: 81, Issue:1

    Topics: Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Diarrhea; Drug Administration Schedule; Drug Eruptions; Endometrial Neoplasms; Feasibility Studies; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy; Radiotherapy, Adjuvant; Risk Factors

2001
Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study.
    Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Drug Hypersensitivity; Esophagitis; Humans; Leukopenia; Life Tables; Lung Neoplasms; Maximum Tolerated Dose; Nausea; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vomiting

2001
A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.
    Medical and pediatric oncology, 2001, Volume: 37, Issue:4

    Topics: Adolescent; Brain; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Survival Analysis; Treatment Outcome

2001
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.
    Seminars in radiation oncology, 2002, Volume: 12, Issue:1 Suppl 1

    Topics: Acute Disease; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Esophagus; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Radiation-Sensitizing Agents; Survival Rate

2002

Other Studies

24 other study(ies) available for paclitaxel and Injuries, Radiation

ArticleYear
Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021, Volume: 197, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Cone-Beam Computed Tomography; Female; Follow-Up Studies; Four-Dimensional Computed Tomography; Hematologic Diseases; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiation Injuries; Radiation Pneumonitis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tumor Burden; Vinorelbine

2021
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
    American journal of clinical oncology, 2015, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Chest Pain; Cohort Studies; Cough; Dyspnea; Esophagitis; Etoposide; Female; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pemetrexed; Radiation Injuries; Radiation Pneumonitis; Retrospective Studies; Treatment Outcome

2015
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
    American journal of clinical oncology, 2017, Volume: 40, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia

2017
Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation.
    Japanese journal of clinical oncology, 2016, Volume: 46, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Retrospective Studies; Taxoids; Treatment Outcome

2016
[Radiotherapy of cervix and endometrial carcinoma].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose Fractionation, Radiation; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Organoplatinum Compounds; Organs at Risk; Paclitaxel; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Uterine Cervical Neoplasms

2016
Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.
    American journal of clinical oncology, 2008, Volume: 31, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Risk Factors

2008
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
    International journal of radiation oncology, biology, physics, 2009, Jul-15, Volume: 74, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Female; Fibrosis; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Skin; Survival Rate; Treatment Outcome

2009
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
    International journal of radiation oncology, biology, physics, 2010, Jun-01, Volume: 77, Issue:2

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Hypothyroidism; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Factors; Taxoids; Thyroid Gland

2010
Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
    The Annals of thoracic surgery, 2009, Volume: 88, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Child; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Infant; Lung; Lung Neoplasms; Lung Volume Measurements; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Postoperative Complications; Prognosis; Pulmonary Alveoli; Pulmonary Diffusing Capacity; Radiation Injuries; Radiotherapy Dosage; Risk Assessment

2009
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.
    The Laryngoscope, 2010, Volume: 120, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Radiation Injuries; Survival Rate

2010
Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.
    International journal of radiation oncology, biology, physics, 2012, Aug-01, Volume: 83, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Tolerance; Radiography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Spinal Cord

2012
Moderately hypofractionated conformal radiation treatment of thoracic esophageal carcinoma.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Radiation Injuries; Radiotherapy, Conformal; Survival Rate; Thoracic Neoplasms

2012
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
    International journal of radiation oncology, biology, physics, 2003, Mar-01, Volume: 55, Issue:3

    Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Confidence Intervals; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Female; Hair; Infusions, Intravenous; Jejunal Diseases; Mice; Mice, Inbred C3H; Ovarian Neoplasms; Paclitaxel; Polyglutamic Acid; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy Dosage; Specific Pathogen-Free Organisms; Taxoids

2003
The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2003, Volume: 15, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Heart; Humans; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiotherapy, Conformal; Retrospective Studies; Stroke Volume

2003
Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2003, Volume: 68, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Hypopharyngeal Neoplasms; Imaging, Three-Dimensional; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Radiation Injuries; Tomography, X-Ray Computed

2003
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
    American journal of clinical oncology, 2005, Volume: 28, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Palliative Care; Radiation Dosage; Radiation Injuries; Remission Induction; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome

2005
Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    International journal of radiation oncology, biology, physics, 2007, Jan-01, Volume: 67, Issue:1

    Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Hysterectomy; Middle Aged; Paclitaxel; Prospective Studies; Radiation Injuries; Radiotherapy Dosage

2007
Radiation-induced myonecrosis presenting as a subcutaneous mass after combined modality therapy for non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Diagnosis, Differential; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Muscle, Skeletal; Necrosis; Paclitaxel; Radiation Injuries; Thorax; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2007
Docetaxel and radiation-recall severe mucositis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:10

    Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Docetaxel; Humans; Lung Neoplasms; Male; Mouth Mucosa; Paclitaxel; Radiation Injuries; Radiotherapy; Stomatitis; Taxoids

1994
Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel.
    Cancer, 1995, Sep-15, Volume: 76, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dermatitis; Female; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Paclitaxel; Radiation Injuries; Radiotherapy

1995
[Neutropenic enterocolitis].
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Biopsy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Palliative Care; Radiation Injuries; Sigmoidoscopy

1998
Highlights of the Eighth European Cancer Conference.
    Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:11

    Topics: Amifostine; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Irinotecan; Neoplasms; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Taxoids; Vinblastine; Vinorelbine

1995
Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy.
    International journal of radiation oncology, biology, physics, 2001, Oct-01, Volume: 51, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Esophagoscopy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Conformal

2001
Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3

    Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Female; Humans; Paclitaxel; Radiation Injuries; Radiotherapy; Skin; Taxoids

2002